Arkpime-T 1.125

Arkpime-T 1.125 Injection is a powerful combination antibiotic formulated with Cefepime 1000mg and Tazobactam 125mg. This advanced formulation is widely used in clinical settings to treat severe and complicated bacterial infections, especially those resistant to standard antibiotics.

Cefepime, a fourth-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, effectively killing a broad range of gram-positive and gram-negative bacteria. Tazobactam enhances this action by blocking beta-lactamase enzymes produced by resistant bacteria, ensuring improved efficacy and extended antibacterial coverage.

Key Benefits

• Broad-spectrum activity against resistant pathogens
• Effective in respiratory, urinary, intra-abdominal, and skin infections
• Synergistic combination for enhanced bacterial eradication
• Suitable for hospital and critical care use

Usage & Administration

Arkpime-T is administered intravenously under medical supervision. Dosage depends on infection severity, patient condition, and physician guidance.

Safety Information

• Use only with a doctor’s prescription
• Monitor for allergic reactions or gastrointestinal disturbances
• Not recommended for self-medication

Conclusion:

Arkpime-T 1.125 Injection stands out as a reliable, high-potency antibiotic solution designed to combat resistant infections effectively. Its dual-action composition ensures superior clinical outcomes, making it a trusted choice in modern antimicrobial therapy.